RMT

Royce Micro-Cap Trust

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 83.3%
Negative

Neutral
PRNewsWire
10 days ago
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026
NEW YORK, May 20, 2026 /PRNewswire/ -- Average weekly trading volume of approximately 641,137 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PRICES AS OF 04/30/26 NAV 14.81 MKT 13.22 AVERAGE ANNUAL TOTAL RETURN AS OF 04/30/26 NAV (%) MKT (%) One-Month* 15.88 16.89 Year to Date* 27.78 28.93 One-Year 72.98 74.60 Three-Year 26.07 26.78 Five-Year 10.83 11.28 10-Year 14.60 15.21 *Not Annualized Important Performance and Expense Information All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance is no guarantee of future results Current performance may be higher or lower than performance quoted.
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026
Neutral
GlobeNewsWire
18 days ago
Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026
RTX001 is an engineered Regenerative Macrophage Therapy for end-stage liver disease (ESLD) with anti-inflammatory and anti-fibrotic properties These new preclinical data demonstrate RTX001's pharmacology, safety, tolerability, and efficacy in mouse models, with reduced fibrosis and inflammation observed Results confirm RTX001's positive preclinical safety and therapeutic profile ahead of interim results from Resolution's Phase I/II EMERALD clinical trial, expected H2 2026 EDINBURGH, United Kingdom and LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Resolution Therapeutics Limited (“Resolution” or “Company”), a clinical-stage biopharmaceutical company pioneering Regenerative Macrophage Therapy (RMT) in inflammatory and fibrotic diseases, will present key preclinical data today on its Regenerative Macrophage Therapy RTX001 in an oral presentation at the ASGCT Annual Meeting, being held from 11-15 May, 2026, in Boston, Massachusetts, US. The presentation will outline Resolution's strategy for testing the safety, biodistribution and pharmacology of RTX001, the Company's engineered RMT.
Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026
Neutral
PRNewsWire
26 days ago
Royce Micro-Cap Trust (NYSE: RMT) as of Mar 31, 2026
NEW YORK, May 4, 2026 /PRNewswire/ -- Average weekly trading volume of approximately 772,582 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PRICES AS OF 03/31/26 NAV 12.78 MKT 11.31 AVERAGE ANNUAL TOTAL RETURN AS OF 03/31/26 NAV (%) MKT (%) One-Month* -5.93 -5.78 Year to Date* 10.26 10.31 One-Year 47.36 44.95 Three-Year 18.33 17.97 Five-Year 8.62 8.95 10-Year 13.33 14.00 *Not Annualized Important Performance and Expense Information All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance is no guarantee of future results Current performance may be higher or lower than performance quoted.
Royce Micro-Cap Trust (NYSE: RMT) as of Mar 31, 2026
Neutral
PRNewsWire
2 months ago
Royce Micro-Cap Trust (NYSE: RMT) as of Feb 28, 2026
NEW YORK, March 25, 2026 /PRNewswire/ -- Average weekly trading volume of approximately 742,172 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PRICES AS OF 02/28/26 NAV 13.82 MKT 12.21   AVERAGE ANNUAL TOTAL RETURN AS OF 02/28/26 NAV (%) MKT (%) One-Month* 7.05 6.27 Year to Date* 17.22 17.07 One-Year 43.30 42.68 Three-Year 19.44 18.55 Five-Year 9.28 9.74 10-Year 14.90 15.56 *Not Annualized Important Performance and Expense Information All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance is no guarantee of future results.
Royce Micro-Cap Trust (NYSE: RMT) as of Feb 28, 2026
Positive
Seeking Alpha
2 months ago
Royce Micro-Cap Trust: What Worked
Eight of the portfolio's 11 equity sectors made a positive impact on calendar year performance, led by Industrials, Materials, and Financials. nLIGHT differentiates itself via vertical integration, domain knowledge, and manufacturing capabilities to deliver cutting edge solutions, increasingly to government and defense organizations. Shares of Sprott outperformed as gold prices broke out to record highs amid elevated geopolitical risk, central bank buying, and a weaker U.S. dollar.
Royce Micro-Cap Trust: What Worked
Neutral
PRNewsWire
2 months ago
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares First Quarter Common Stock Distribution of $0.19 Per Share
NEW YORK, March 2, 2026 /PRNewswire/ -- Royce Micro-Cap Trust, Inc. (NYSE-RMT) has declared a quarterly distribution of $0.19 per share on its Common Stock.  The distribution, optionally payable in additional shares of Common Stock, or in cash by specific stockholder election, is to be paid on March 30, 2026, to stockholders of record at the close of business on March 12, 2026 (ex-dividend on March 12, 2026).
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares First Quarter Common Stock Distribution of $0.19 Per Share
Neutral
PRNewsWire
3 months ago
Royce Micro-Cap Trust (NYSE: RMT) as of Jan 31, 2026
NEW YORK, Feb. 27, 2026 /PRNewswire/ --  Average weekly trading volume of approximately 684,629 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PRICES AS OF 01/31/26 NAV 12.91 MKT 11.49 AVERAGE ANNUAL TOTAL RETURN AS OF 01/31/26 NAV (%) MKT (%) One-Month* 9.50 10.16 One-Year 25.47 26.00 Three-Year 15.65 15.76 Five-Year 9.87 10.58 10-Year 14.12 14.97 *Not Annualized Important Performance and Expense Information All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance is no guarantee of future results Current performance may be higher or lower than performance quoted.
Royce Micro-Cap Trust (NYSE: RMT) as of Jan 31, 2026
Neutral
PRNewsWire
4 months ago
Royce Micro-Cap Trust (NYSE: RMT) as of Dec 31, 2025
NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Average weekly trading volume of approximately 429,716 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PRICES AS OF 12/31/25 NAV 11.79 MKT 10.43 AVERAGE ANNUAL TOTAL RETURN AS OF 12/31/25 NAV (%) MKT (%) One-Month* 1.69 2.00 One-Year 16.57 16.13 Three-Year 15.55 15.38 Five-Year 8.85 9.51 10-Year 12.23 12.75 *Not Annualized Important Performance and Expense Information All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance is no guarantee of future results Current performance may be higher or lower than performance quoted.
Royce Micro-Cap Trust (NYSE: RMT) as of Dec 31, 2025
Positive
Seeking Alpha
4 months ago
RMT: An 8% Plus Yield, 12% Discount, And Exposure To Micro-Cap Equity Space
Royce Micro-Cap Trust offers unique micro-cap equity exposure, an 8% plus yield, and currently trades at a -12% NAV discount. RMT has matched S&P 500 long-term returns (10.9% NAV annualized) while providing substantially higher income, making it attractive for income-focused diversification. With minimal leverage, active management, and a managed distribution policy, RMT's distributions are sustainable and primarily sourced from capital gains.
RMT: An 8% Plus Yield, 12% Discount, And Exposure To Micro-Cap Equity Space
Neutral
PRNewsWire
5 months ago
Royce Micro-Cap Trust (NYSE: RMT) as of Nov 30, 2025
NEW YORK , Dec. 23, 2025 /PRNewswire/ -- Average weekly trading volume of approximately 556,750 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PRICES AS OF 11/30/25 NAV                                                   11.86 MKT 10.46 AVERAGE ANNUAL TOTAL RETURN AS OF 11/30/25 NAV (%) MKT (%) One-Month* -0.25 -0.85 Year to Date* 14.63 13.85 One-Year 9.03 9.95 Three-Year 13.78 12.97 Five-Year 10.21 11.03 10-Year 11.67 12.28 *Not Annualized Important Performance and Expense Information All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance is no guarantee of future results Current performance may be higher or lower than performance quoted.
Royce Micro-Cap Trust (NYSE: RMT) as of Nov 30, 2025